CFDB - Cystic Fibrosis DataBase

at least one term
all terms

Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.

primary studies  published RCT

Details
  • 2016
  • Brivio A

Infant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis.

primary studies  published RCT

Details
  • 2016
  • Davis SD

A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.

primary studies  published RCT

Details
  • 2016
  • Dentice RL

Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.

primary studies  published RCT

Details
  • 2016
  • Elborn JS

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.

primary studies  published RCT

Details
  • 2016
  • Flume PA

Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis.

primary studies  published RCT

Details
  • 2016
  • Flume PA

Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.

primary studies  published RCT

Details
  • 2016
  • Gaggar A

A Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.

primary studies  published RCT

Details
  • 2016
  • Hermes WA

Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.

primary studies  published RCT

Details
  • 2016
  • Heubi JE

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

primary studies  published RCT

Details
  • 2016
  • Konstan MW